A new inhibitor of the transcription-termination factor Rho

Biochem Biophys Res Commun. 2003 Mar 7;302(2):219-25. doi: 10.1016/s0006-291x(03)00131-1.

Abstract

In this study we describe BI-K0058, a new inhibitor of the transcription-termination factor Rho belonging to a different chemical class from bicyclomycin, the only known antibiotic acting on Rho. BI-K0058 inhibits the poly(C)-dependent ATPase activity of Rho with an IC(50) of 25 microM as well as in vitro transcription-termination of two natural substrates, the Salmonella enterica hisG cistron and the f1 phage intergenic region. BI-K0058 does not affect photolabeling of Rho by ATP. The results of gel mobility shift experiments with a natural RNA substrate demonstrate that BI-K0058 inhibits the formation of the ATP-independent high affinity Rho-RNA complex.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Benzimidazoles / chemistry
  • Benzimidazoles / pharmacology*
  • Bridged Bicyclo Compounds, Heterocyclic / chemistry
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
  • Microbial Sensitivity Tests
  • Moraxella / drug effects
  • Neisseria gonorrhoeae / drug effects
  • RNA / drug effects
  • RNA / metabolism
  • Rho Factor / antagonists & inhibitors*

Substances

  • Anti-Bacterial Agents
  • BIK0058
  • Benzimidazoles
  • Bridged Bicyclo Compounds, Heterocyclic
  • Rho Factor
  • RNA
  • Adenosine Triphosphate
  • bicozamycin